Advertisement

Phagocytic Cell Functions in Diabetes Mellitus

  • Michael E. Miller

Abstract

The mechanisms by which the patient with diabetes mellitus demonstrates increased susceptibility to infections have aroused much interest. Consideration of possible de fects has been divided into two major areas. In the first, potential abnormalities of the T- and/or B-cell system and their effects upon immunological functions in the diabetic patient have been probed. These studies are extensive and are reviewed elsewhere in this text (Chapter 11). The second group of studies has concerned a different component of the host defense system; the phagocytic cell lines. Although more contemporary in terms of active investigation, a sizable literature now exists through which investigators have implicated primary granulocyte dysfunctions as (a) major contributing factor(s) to infection in the diabetic host (Bagade, 1976). In this chapter, I will review the evidence for possible phagocytic dysfunction as a primary or major secondary cause of infections in the diabetic patient. These studies will then be summarized with reference to the limitations of in vitro assays of phagocyte function.

Keywords

Diabetic Patient Diabetic Subject Polymorphonuclear Leukocyte Chronic Granulomatous Disease Neurogenic Bladder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ackerman, S. K., and Douglas, S. D., 1979, Pepstatin A—a human leukocyte chemoattractant, Clin. Immunol. Immunopathol. 14: 244–250.PubMedCrossRefGoogle Scholar
  2. Bagdade, J. D., 1976, Phagocytic and microbicidal function in diabetes mellitus, Acta Endocrinol. (Copenh.) 83 (Suppl. 205): 27–33.Google Scholar
  3. Bagdade, J. D., and Steward, M., 1976, Host defense in diabetes mellitus: Impaired granulocyte adherence in poorly controlled diabetic patients (abstract,) Clin. Res. 24: 112A.Google Scholar
  4. Bailey, H., 1961, Cystitis emphysematosa: 19 cases with intraluminal and interstitial collections of gas, AJR 86: 850–862.Google Scholar
  5. Baldwin, A. D., and Root, H. F., 1940, Infections of upper urinary tract in diabetic patients, N. Engl. J. Med. 223: 244–250.CrossRefGoogle Scholar
  6. Becker, E. L., 1976, Some interrelations among chemotaxis, lysosomal enzyme secretion and phagocytosis by neutrophils, in: Molecular and Biological Aspects of the Acute Allergic Reaction ( S. G. O. Johanson, K. Strandberg, and B. Uvnas, eds.), pp. 353–370, Plenum Press, New York.CrossRefGoogle Scholar
  7. Becker, E. L., and Showell, H. J., 1974, The ability of chemotactic factors to induce lysosomal enzyme release. II. The mechanism of release, J. Immunol. 112: 2055–2062.PubMedGoogle Scholar
  8. Bessman, A. N., and Wagner, W., 1975, Nonclostridial gas gangrene, DAMA 233: 958–963.Google Scholar
  9. Boxer, L. A, Hedley-Whyte, E. T., and Stossel, T. P., 1974, Neutrophil actin dysfunction and abnormal neutrophil behavior, N. Engl. J. Med. 291: 1093–1099.PubMedCrossRefGoogle Scholar
  10. Boyden, S., 1962, Chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes, J. Exp. Med. 115: 453–466.PubMedCrossRefGoogle Scholar
  11. Bybee, J. D., and Rogers, D. E., 1964, The phagocytic activity of polymorphonuclear leukocytes obtained from patients with diabetes mellitus, J. Lab. Clin. Med.: 64: 1–13.PubMedGoogle Scholar
  12. Cheung, A. T. W, Miller, M. E., and Keller, S. R., 1982, Movement of human polymorphonuclear leukocytes: A videotape analysis, J. Reticuloendothel. Soc., 1: 31193–205, 1982.Google Scholar
  13. Cohn, L. S., Fekety, F. R., and Cluff, L. E., Studies on the epidemiology of staphylococcal infection. VI. Infections in the surgical patient, Ann. Surg. 159: 321, 1964.CrossRefGoogle Scholar
  14. Crosby, B., and Allison, F., Jr., 1966, Phagocytic and bactericidal capacity of polymorphonuclear leukocytes recovered from venous blood of human beings, Proc. Soc. Exp. Biol. Med. 123: 660–664.PubMedGoogle Scholar
  15. Drachman, R. H., Root, R. K., and Wood, W. B., Jr., 1966, Studies on the effect of experimental nonketotic diabetes mellitus on antibacterial defense. I. Demonstration of a defect in phagocytosis, J. Exp. Med. 124: 227–240.PubMedCrossRefGoogle Scholar
  16. Dubos, R. J., 1953, Effect of ketone bodies and other metabolites on the survival and multiplication of staphylococci and tubercle bacilli, J. Exp. Med. 98: 145–155.PubMedCrossRefGoogle Scholar
  17. Edmondson, H. A., Martin, H. E., and Evans, N., 1947, Necrosis of renal papillae and acute pyelonephritis in diabetes mellitus, Arch. Intern. Med. 79: 148–175.CrossRefGoogle Scholar
  18. Edwards, J. E., Jr., Tillman, D. B., Miller, M. E., and Pitchon, H. E., 1979, Infection and diabetes mellitus-Teaching Conference, Harbor-University of California, Los Angeles, Medical Center, Torrance, and VA Wadsworth Medical Center, Los Angeles (Specialty Conference). West J. Med. 130: 515–521.Google Scholar
  19. Ellenberg, M., and Weber, H., 1967, Incipient asymptomatic diabetic bladder, Diabetes 16: 331–335.PubMedGoogle Scholar
  20. Esmann, V., 1972, The diabetic leukocyte, Enzyme 13: 32–55.PubMedGoogle Scholar
  21. Gallin, J. I., and Quie, P. G. (eds.), 1978, Leukocyte Chemotaxis: Methods, Physiology, and Clinical Implications, Raven Press, New York.Google Scholar
  22. Gallin, J. E., Gallin, E. K., Mallech, H. L., and Cramer, E. B., 1978, Structural and ionic events during leukocyte chemotaxis, in: Leukocyte Chemotaxis ( J. I. Gallin and P. G. Quie, eds.), pp. 123–141, Raven Press, New York.Google Scholar
  23. Goetzl, E. J., and Austen, K. F., 1974, Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotatic factors, J. Clin. 53: 591–599.Google Scholar
  24. Goetzl, E. J., and Sun, F. F., 1979, Generation of unique monohydroxyeicosatetraenoic acids from arachinoid acid by human neutrophils, J. Exp. Med. 150: 406–411.PubMedCrossRefGoogle Scholar
  25. Halverstadt, D. B., Leadbetter, G. W., Jr., and Field, R. A., 1966, Pyelonephritis in the diabetic. Correlation of open renal biospsies and bacteriologic studies, JAMA 195: 827–829.PubMedCrossRefGoogle Scholar
  26. Henson, P. M., 1976, Membrane receptors on neutrophils, Immunol. Commun. 5: 757–775.PubMedGoogle Scholar
  27. Hill, H. R., 1978, Cyclic nucleotides as modulators of leukocyte chemotaxis, in: Leukocyte Chemotasis ( J. I. Gallin and P. G. Quie, eds.), pp. 179–193, Raven Press, New York.Google Scholar
  28. Hill, H. R., Sauls, H. S., Dettlof, J. L., and Quie, P. G., 1974, Impaired leukotactic responsiveness in patients with juvenile diabetes mellitus, Clin. Immunol. Immunopathol. 2: 395–403.PubMedCrossRefGoogle Scholar
  29. Humbert, J. R., Hambridge, K. M., Moore, L. L., Lindstrom, S. A., and Martinez, B., 1976, Absence of neutrophil chemotactic defect in diabetes, Clin. Res. 24: 180A.Google Scholar
  30. Huvos, A., and Rocha, H., 1959, Frequency of bacteriuria patients with diabetes mellitus, N. Engl. J. Med. 261: 1213–1216.PubMedCrossRefGoogle Scholar
  31. Johnson, J. E., 1970, Infection in diabetes, in: Diabetes Mellitus: Theory and Practice, ( M. Ellenberg and H. Rifkin, eds.), p. 739, McGraw-Hill, New York.Google Scholar
  32. Johnston, R. B., Jr. and Newman, S. L., 1977, Chronic granulomatous disease, Pediat. Clin. North Am. 24: 365–376.Google Scholar
  33. Knight, L. and Fletcher, J., 1971, Growth of Candida albicans in saliva: Stimulation by glucose associated with antibotics, corticosteroids, and diabetes mellitus, J. Infect. Dis. 123: 371–377.PubMedCrossRefGoogle Scholar
  34. Lauler, D. P., Schreiner, G. E., and David, A., 1960, Renal medullary necrosis, Am. J. Med. 29: 132–156.PubMedCrossRefGoogle Scholar
  35. Long, E. R., 1930, A chemical view of the pathogenesis of tuberculosis, Am. Rev. Tubercul. 22: 467–490.Google Scholar
  36. Marble, A., White, H. J., and Fernald, A. T., 1938, The nature of the lowered resistance to infection in diabetes mellitus, J. Clin. Invest. 17: 423–430.PubMedCrossRefGoogle Scholar
  37. Miller, M. E., and Baker, L., 1972, Leukocyte functions in juvenile diabetes mellitus: Humoral and cellular aspects, J. Pediatr. 81: 979–982.PubMedCrossRefGoogle Scholar
  38. Miller, M. E., and Myers, K. A., 1975, Cellular deformability of the human peripheral blood polymorphonuclear leukocyte: Method of study, normal variation and effects of physical and chemical alterations, J. Reticuloendothel. Soc. 18: 337–345.PubMedGoogle Scholar
  39. Mowat, A., and Baum, J., 1971, Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus, N. Engl. J. Med. 284: 621–627.PubMedCrossRefGoogle Scholar
  40. Muller, L. M., and Higgins, G. K., 1963, Incidence of undiscovered adult diabetes in a tuberculosis sanitarium, Canad. Med. Assoc. J. 88: 424–425.Google Scholar
  41. Murphy, S., and Miller, M. E., 1977, Impaired movement and deformability of neutrophils from patients with juvenile diabetes mellitus. An insulin induced defect? Pediatr. Res. 11 (No. 4): 520 (abstract).CrossRefGoogle Scholar
  42. Nolan, C. M., Beaty, H. N., and Bagdade, J. D, 2978, Further characterization of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes, Diabetes 27: 889–894.Google Scholar
  43. Pell, S., and D’Alonzo, C. A., 1967, Sickness absenteeism in employed diabetics, Am. J. Public Health 57: 253–260.CrossRefGoogle Scholar
  44. Pell, S., and D’Alonzo, C. A., 1970, Factors associated with long-term survival of diabetics, JAMA 214: 1833–1840.PubMedCrossRefGoogle Scholar
  45. Pometta, D., Rees, S. B., Younger, D., and Kass, E. H., 1967, Asymptomatic bacteriuria in dieabetes mellitus, N. Engl. J. Med. 276: 1118–1121.PubMedCrossRefGoogle Scholar
  46. Repine, J. E., Clawson, C. C., and Goetz, F. C., 1980, Bactericidal function of neutrophils from patients with acute bacterial infections and from diabetes, J. Infect. Dis. 142(No. 6):869–875PubMedCrossRefGoogle Scholar
  47. Richardson, R., 1942, Immunity in diabetes. IV. Measurements of phagocytic activity in diabetes mellitus. Am. J. Med. Sci. 204: 29–35.CrossRefGoogle Scholar
  48. Robbins, S. L., and Tucker, A. W., Jr., 1944, The cause of death in diabetes: A report of 307 autopsied cases, N. Engl. J. Med. 231: 865–868.CrossRefGoogle Scholar
  49. Robson, M. D., and Heggers, J. R., 1969, Effect of hyperglycemia on survival of bacteria, Surg. Forum 20: 56–57.PubMedGoogle Scholar
  50. Sheldon, W. H., and Bauer, H., 1959, The development of acute inflammatory response to experimental mucormycosis in normal and diabetic rabbits, J. Exp. Med. 110: 845–852.PubMedCrossRefGoogle Scholar
  51. Sheldon, W. H., and Bauer, H., 1962, The role of predisposing factors in experimental fungal infections, Lab. Invest. 11: 1184–1191.Google Scholar
  52. Smith, J. A., O’Connor, J. J. and Willis, A. T., 1966, Nasal carriage of Staphylococcus aureus in diabetes mellitus, Lancet 2: 766–666.Google Scholar
  53. Stossel, T. P., 1975, Phagocytosis: Recognition and ingestion, Semin. Hermatol. 12: 83–116.Google Scholar
  54. Stossel, T. P., 1978, The mechanism of leukocyte locomotion, in: Leukocyte Chemotaxis ( J. I. Gallin and P. G. Quie, eds.), pp. 143–160, Raven Press, New York.Google Scholar
  55. Stossel, T. P., and Hartwig, J. H., 1976, Interaction of actin, myosin, and a new actin-binding protein of rabbit pulmonary macrophage. II. Role in cytoplasmic movement and phagocytosis, J. Cell Biol. 68: 602–619.PubMedCrossRefGoogle Scholar
  56. Tan, J. S., Anderson, J. L., Watanakunakorn, C., and Phair, J. P., 1975, Neutrophil dysfunction in diabetes mellitus, J. Lab. Clin. Med. 85: 26–33.PubMedGoogle Scholar
  57. Tuajon, C. U., Perez, A., Kishaba, T., and Sheagren, J. N., 1975, Staphylococcus aureus among insulin-injecting diabetic patients, JAMA 231: 1272.CrossRefGoogle Scholar
  58. Vejlsgaard, R., 1965, Significant bacteriuria in relation to vascular disease of diabetics of long duration, in: Progress in Pyelonephritis ( E. H. Kass, ed.), pp. 492–500, F. A. Davis, Philadelphia.Google Scholar
  59. Viollier, A. F., and Senn, H. J., 1979, Granulozytäre Infektabwehr bei Diabetes Mellitus unter besonderer Berücksichtigung der Bakterizidie, Schweiz. Med. Wochenschr. 109: 1896.PubMedGoogle Scholar
  60. Warren, S., Le Compte, P. M., and Legg, M. A., 1966, The Pathology of Diabetes Mellitus, 4th Edition, Lea and Febiger, Philadelphia.Google Scholar
  61. Weaver, R. A., 1974, Unusual radiographic presentation of pulmonary tuberculosis in diabetic patients, Am. Rev. Resp:r. Dis. 109: 162–163.Google Scholar
  62. Wilkinson, P. C., 1976, Recognition and response in mononuclear and granular phagocytes, Clin. Exp. lmmunol. 25: 355–366.Google Scholar
  63. Wilkinson, P. C., and Allan, R. B., 1978, Assay systems for measuring leukocyte locomotion: an overview, in: Leukocyte Chemotaxis ( J. I. Gallin and P. G. Quie, eds.), pp. 1–24. Raven Press, New York.Google Scholar
  64. Younger, D., and Hadley, W. B., 1971, Infection and diabetes, in: Joslin’s Diabetes Mellitus ( A. Marble and P. White, eds.), p. 628, Lea and Febiger, Philadelphia.Google Scholar
  65. Zaky, D. A., Bentley, D. W., Lowy, K., Betts, R. F., and Douglas, R. G., 1976, Malignant external otitis: A severe form of otitis in diabetic patients, Am J. Med. 61:298–302.PubMedCrossRefGoogle Scholar
  66. Zigmond, S. H., 1978, A new visual assay of leukocyte chemotaxis, in: Leukocyte Chemotaxis ( J. I. Gallin and P. G. Quie, eds), pp. 57–66, Raven Press, New York.Google Scholar

Copyright information

© Plenum Publishing Corporation 1984

Authors and Affiliations

  • Michael E. Miller
    • 1
  1. 1.Department of PediatricsUniversity of California at DavisSacramentoUSA

Personalised recommendations